MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0030199
Chempro Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹37.02 Cr
▼ 12% YoY
Net profit · FY 2025
₹43.36 Lakh
Net margin 1.2%
EBITDA · FY 2025
₹84.8 Lakh
EBITDA margin 2.3%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1.19 Lakh
Issued & subscribed
Open charges
₹2 Cr
Satisfied ₹3 Cr
Company age
18 yrs
Est. 2008
Directors on board
5
As per MCA filings
About Chempro Pharma Private Limited
Data last updated:
Chempro Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 17 May 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2008PTC182363. Its GSTIN is 27AADCC3689H1ZE (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1.19 Lakh. It is led by directors including Deepkiran Shantaram Khanwalkar and Arun Sehgal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1st Floor Pushpawati Building No. 1 568 Girgaon Road Chira Bazar, Mumbai, Maharashtra, India – 400002.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.02 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹43.36 Lakh (net margin 1.2%) and EBITDA of ₹84.8 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 9% over five years.
The company is associated with 1 brand: Chempro Pharma. As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹3 Cr on record. Court records list 10 cases involving the company, including 4 filed by the company and 6 filed against it; 1 case is pending.
Chempro Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0030199). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website chemprogroup.com.
Company Details of Chempro Pharma Private Limited
CIN U24230MH2008PTC182363
Registration Number 182363
Incorporation Date 17 May 2008
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0030199
Key People
Deepkiran Shantaram Khanwalkar Director Shubhit Arun Sehgal Additional Director Arun Sehgal Director Recognitions & Rankings of Chempro Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address1st Floor Pushpawati Building No. 1 568 Girgaon Road Chira Bazar, Mumbai, Maharashtra, India – 400002
- IndustryPharma, API Manufacturers
Comprehensive company report
Chempro Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Chempro Pharma Private Limited
Chempro Pharma operates one associated brand: Chempro Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| APIs are manufactured and formulations are contract-produced by Chempro Pharma. | chemprogroup.com |
Business Activity of Chempro Pharma Private Limited
The main business activity of Chempro Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Chempro Pharma Private Limited FY 2025 filings available
Chempro Pharma Private Limited reported revenue of ₹37.02 Cr (down 12% YoY) for FY 2025.
Revenue · FY 2025
₹37.02 Cr ▼ 12%
Net profit · FY 2025
₹43.36 Lakh margin 1.2%
EBITDA · FY 2025
₹84.8 Lakh margin 2.3%
Compounded Annual Growth Rate (CAGR) of Chempro Pharma Private Limited
Revenue CAGR growth
1 year
▼ 12%
3 years · compounded
▲ 21%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 441%
3 years · compounded
▲ 17%
5 years · compounded
▼ 1%
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA rose 441% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Chempro Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹84.8 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹43.36 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Chempro Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Chempro Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Chempro Pharma Private Limited
Chempro Pharma has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepkiran Shantaram Khanwalkar | Director | 18 Dec 2009 | 16 Years 10 Months | Current |
| Shubhit Arun Sehgal | Additional Director | 12 Mar 2025 | 1 Years 7 Months | Current |
| Arun Sehgal | Director | 17 May 2008 | 18 Years 5 Months | Current |
| Vijay Shyamsunder Agarwal | Director | 17 May 2008 | 18 Years 5 Months | Current |
| Vandan Vijay Agarwal | Director | 03 Apr 2023 | 3 Years 6 Months | Current |
Peer Comparison of Chempro Pharma Private Limited
Chempro Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Auroactive Pharma Private Limited | ₹37.55 Cr (FY 2025) | •••• | •••• | 8244.0% | •••• | Hyderabad, Telangana, India |
| Shree Nath Life Sciences Private Limited | ₹37.39 Cr (FY 2025) | •••• | •••• | -28.0% | •••• | Delhi, India |
| Nira Life Sciences Private Limited | ₹37.1 Cr (FY 2024) | •••• | •••• | -18.0% | •••• | Rajkot, Gujarat, India |
| Nandesari Drugs and Pharmaceuticals Private Limited | ₹37.08 Cr (FY 2024) | •••• | •••• | 1417.0% | •••• | Delhi, India |
| Globela Industries Private Limited | ₹37.05 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Vagra, Gujarat, India |
| Chempro Pharma Private Limited this company | ₹37.02 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Mumbai, Maharashtra, India |
| Acura Labs Private Limited | ₹36.83 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Yadadri Bhuvanagiri, Telangana, India |
| Nam Group of Industries Private Limited | ₹36.7 Cr (FY 2024) | •••• | •••• | -19.0% | •••• | Mumbai, Maharashtra, India |
| Rank Organics Chemical Private Limited | ₹36.34 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Mumbai, Maharashtra, India |
| Vasundhara Rasayans Limited Listed | ₹36.34 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Hyderabad, Telangana, India |
| Yms Laboratories Private Limited | ₹36.29 Cr (FY 2024) | •••• | •••• | 34.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Chempro Pharma by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Chempro Pharma Private Limited
Chempro Pharma Private Limited is audited by R J B V & ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R J B V & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Chempro Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Chempro Pharma Private Limited
Open charges
₹2 Cr
Satisfied charges
₹3 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2017 | Others | ₹2 Cr | Open |
| 02 Sep 2013 | Deutsche Bank Ag | ₹3 Cr | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Chempro Pharma Private Limited
Chempro Pharma Private Limited has 10 court cases on record: 4 filed by Chempro Pharma, 6 filed against it. 1 case is pending and 9 are disposed. Status as checked between 01 Oct 2026 and 04 Oct 2026.
Total cases
10
Filed by the company
4
Filed against the company
6
Pending
1
Disposed
9
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 4 | 0 |
| High courts | 2 | 2 | 1 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Gujarat | Court case (AO) | Filed against the company by Lincoln Pharmaceuticals Ltd | Disposed |
| District court, Anand, Gujarat | Criminal complaint | Filed by the company against Manav Drugs Private Limited | Disposed |
| High Court of Delhi | Appeal | Filed against the company by an individual | Pending |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by Linkolan Pharmacutecals Ltd | Disposed |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by Linkolan Pharmacutecals Ltd | Disposed |
Premium access
Full case history
All 10 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Chempro Pharma Private Limited
Employment history and EPFO contributions of people linked to Chempro Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Chempro Pharma Private Limited
Chempro Pharma Private Limited has 9 board changes on record since 2008: 5 appointments and 4 cessations. The latest: Shubhit Arun Sehgal was appointed as Additional Director on 12 Mar 2025.
AGM
Chempro Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Chempro Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Shubhit Arun Sehgal was appointed as Additional Director.
Ceased
Vandan Vijay Agarwal ceased to be Additional Director.
Ceased
Shubhit Arun Sehgal ceased to be Additional Director.
Appointed
Vandan Vijay Agarwal was appointed as Director.
Charges
A charge registered on 02 Sep 2013 via Charge ID 10453154 with Deutsche Bank Ag was fully satisfied on 03 Apr 2017.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100092308 was registered on 27 Mar 2017.
Ceased
Vishal Vijay Agarwal ceased to be Director.
Ceased
Ankit Arun Sehgal ceased to be Director.
Charges
A charge with Deutsche Bank Ag amounted to Rs. 3.00 Cr with Charge ID 10453154 was registered on 02 Sep 2013.
Appointed
Deepkiran Shantaram Khanwalkar was appointed as Director.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Chempro Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Chempro Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Chempro Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Chempro Pharma Private Limited
Chempro Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCC3689H1ZE | Maharashtra | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Chempro Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Chempro Pharma Private Limited
Frequently Asked Questions about Chempro Pharma Private Limited
Chempro Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 17 May 2008 (18+ years old) and is registered under CIN U24230MH2008PTC182363.
Chempro Pharma reported revenue of ₹37.02 Cr for FY 2025 (down 12% YoY).
Chempro Pharma has 5 current directors:
- Deepkiran Shantaram Khanwalkar - Director
- Shubhit Arun Sehgal - Additional Director
- Arun Sehgal - Director
- Vijay Shyamsunder Agarwal - Director
- Vandan Vijay Agarwal - Director
Chempro Pharma reported a net profit of ₹43.36 Lakh (net margin 1.2%) and EBITDA of ₹84.8 Lakh (EBITDA margin 2.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Chempro Pharma is 21% over three years and 9% over five years. In the latest year (FY 2025) revenue fell 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Chempro Pharma is 27AADCC3689H1ZE, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Chempro Pharma is U24230MH2008PTC182363. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chempro Pharma has 10 court cases on record: 4 filed by the company and 6 filed against it. 1 is pending. Most are in the district courts.
Chempro Pharma was incorporated on 17 May 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Chempro Pharma by revenue are Auroactive Pharma Private Limited, Shree Nath Life Sciences Private Limited, Nira Life Sciences Private Limited, Nandesari Drugs and Pharmaceuticals Private Limited, Globela Industries Private Limited and 5 more, all in the Pharma industry (API Manufacturers).
Shubhit Arun Sehgal was appointed as Additional Director on 12 Mar 2025. Vandan Vijay Agarwal ceased to be Additional Director on 29 Sep 2023. Shubhit Arun Sehgal ceased to be Additional Director on 03 Apr 2023. Chempro Pharma has 9 board changes on record in total.